Possible roles of tumor necrosis factor-α and angiotensin II type 1 receptor on high glucose-induced damage in renal proximal tubular cells

Renal Failure

Volumn 37, Issue 1, 2015, Pages 160-164

  Takao, Toshihiro ^a   Horino, Taro ^b   Matsumoto, Reiko ^b   Shimamura, Yoshiko ^b   Ogata, Koji ^b   Inoue, Kousuke ^b   Taniguchi, Yoshinori ^b   Taguchi, Takafumi ^b   Terada, Yoshio ^b  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II type 1 (AT1) receptor; HK2 cells; N acetyl beta glucosaminidase; P22phox; Tumor necrosis factor alpha

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CANDESARTAN; GLUCOSE; N ACETYL BETA GLUCOSAMINIDASE; PROTEIN P22; SMALL INTERFERING RNA; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; ACETYLGLUCOSAMINIDASE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ARTICLE; CELL DAMAGE; CONTROLLED STUDY; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; RENAL PROXIMAL TUBULAR EPITHELIAL CELL; SIGNAL TRANSDUCTION; CELL CULTURE; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

ACETYLGLUCOSAMINIDASE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLUCOSE; HUMANS; KIDNEY TUBULES, PROXIMAL; OXIDATIVE STRESS; RECEPTOR, ANGIOTENSIN, TYPE 1; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919416204     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.959434     Document Type: Article

References (33)

1. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl. 2011;(120):S1-S6.
2. Vallon V, Platt KA, Cunard R, et al. SGLT2 mediates glucose reabsorption in the early proximal tubule. J Am Soc Nephrol. 2011; 22(1):104-112.
3. Dzau VJ, Paul M, Nakamura N, Pratt RE, Ingelfinger JR. Role of molecular biology in hypertension research. State of the art lecture. Hypertension. 1989;13(6 Pt 2):731-740.
4. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest. 1990;85(2):417-423.
5. Wolf G, Neilson EG. Effects of angiotensin II on proximal tubular cells stably transfected with the c-mas oncogene. Am J Physiol. 1992;263(5 Pt 2):F931-F938.
6. Loghman-Adham M, Rohrwasser A, Helin C, et al. A conditionally immortalized cell line from murine proximal tubule. Kidney Int. 1997;52(1):229-239.
7. Burns KD, Inagami T, Harris RC. Cloning of a rabbit kidney cortex AT1 angiotensin II receptor that is present in proximal tubule epithelium. Am J Physiol. 1993;264(4 Pt 2):F645-F654.
8. Lai KN, Leung JC, Lai KB, To WY, Yeung VT, Lai FM. Gene expression of the renin-angiotensin system in human kidney. J Hypertens. 1998;16(1):91-102.
9. Andersen S, Tarnow L, Rossing P, Hansen BV, Parving HH. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000; 57(2):601-606.
10. Zimpelmann J, Kumar D, Levine DZ, et al. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 2000;58(6):2320-2330.
11. Takao T, Horino T, Kagawa T, et al. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. J Nephrol. 2011; 24(2):218-224.
12. Zhang SL, To C, Chen X, et al. Essential role(s) of the intrarenal renin-angiotensin system in transforming growth factor-beta1 gene expression and induction of hypertrophy of rat kidney proximal tubular cells in high glucose. J Am Soc Nephrol. 2002; 13(2):302-312.
13. Moresco RN, Sangoi MB, De Carvalho JA, Tatsch E, Bochi GV. Diabetic nephropathy: Traditional to proteomic markers. Clin Chim Acta. 2013;421:17-30.
14. Ortiz A, Egido J. Is there a role for specific anti-TNF strategies in glomerular diseases? Nephrol Dial Transpl. 1995;10(3):309-311.
15. Zhang B, Ramesh G, Norbury CC, Reeves WB. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int. 2007;72(1):37-44.
16. Kitada K, Nakano D, Hitomi H, et al. Aldosterone induces p21-regulated apoptosis via increased synthesis and secretion of tumour necrosis factor-alpha in human proximal tubular cells. Clin Exp Pharmacol Physiol. 2012;39(10):858-863.
17. Sachse A, Wolf G. Angiotensin II-induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18(9):2439-2446.
18. Hennet T, Richter C, Peterhans E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem J. 1993;289(Pt 2):587-592.
19. Sonta T, Inoguchi T, Matsumoto S, et al. In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker. Biochem Biophys Res Commun. 2005;330(2):415-422.
20. Kagawa T, Takao T, Horino T, et al. Angiotensin II receptor blocker inhibits tumour necrosis factor-alpha-induced cell damage in human renal proximal tubular epithelial cells. Nephrology (Carlton). 2008;13(4):309-315.
21. Takao T, Horino T, Kagawa T, et al. Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells. Am J Nephrol. 2009; 29(2):102-108.
22. Zhou L, Xue H, Yuan P, et al. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. Clin Exp Pharmacol Physiol. 2010; 37(9):e152-e157.
23. Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR. Tumor necrosis factor receptors: Biology and therapeutic potential in kidney diseases. Am J Nephrol. 2012; 36(3):261-270.
24. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology. 2002;143(8):2975-2985.
25. Yang CM, Lee IT, Hsu RC, Chi PL, Hsiao LD. NADPH oxidase/ROS-dependent PYK2 activation is involved in TNF-alpha-induced matrix metalloproteinase-9 expression in rat heart-derived H9c2 cells. Toxicol Appl Pharmacol. 2013;272(2):431-442.
26. Zhang C, Hein TW, Wang W, Ren Y, Shipley RD, Kuo L. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J Mol Cell Cardiol. 2006;40(2):247-257.
27. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST. Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol. 2004;286(4):C779-C784.
28. Sasamura H, Nakazato Y, Hayashida T, Kitamura Y, Hayashi M, Saruta T. Regulation of vascular type 1 angiotensin receptors by cytokines. Hypertension. 1997;30(1 Pt 1):35-41.
29. Shi P, Diez-Freire C, Jun JY, et al. Brain microglial cytokines in neurogenic hypertension. Hypertension. 2010;56(2):297-303.
30. Lu Y, Chen J, Yin X, Zhao H. Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1 beta in the paraventricular nucleus. Neurol Res. 2009;31(4):420-424.
31. Li Z, Chen XD, Ni SK, Li JW, Lin MS. Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse. Chin J Traumatol. 2004;7(1):56-61.
32. Araujo AA, Lopes de Souza G, Souza TO, et al. Olmesartan decreases IL-1beta and TNF-alpha levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. Naunyn Schmiedeberg's Arch Pharmacol. 2013;386(10):875-884.
33. Kataoka H, Murakami R, Numaguchi Y, Okumura K, Murohara T. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells. Eur J Pharmacol. 2010;636(1-3):36-41.